The Medical Benefits of Cannabis: What the Evidence Actually Shows

The Medical Benefits of Cannabis: What the Evidence Actually Shows

Cannabis—often called marijuana—has been used medicinally for centuries, but modern research paints a more nuanced picture than either “miracle cure” or “dangerous drug.” Certain cannabis-derived medicines have proven clinical benefits, while many other proposed uses remain under investigation. Understanding the difference between cannabis itself, its active compounds, and standardized prescription medicines is essential.



How medicinal cannabis works

Cannabis contains more than 100 compounds known as cannabinoids. The two best known are:

• Tetrahydrocannabinol (THC): Produces the intoxicating “high” associated with cannabis and may also reduce pain, nausea, and muscle spasticity.
• Cannabidiol (CBD): Does not generally cause intoxication but can affect the nervous system and interact with medications.

These compounds influence the body’s endocannabinoid system, which helps regulate processes including pain, appetite, mood, memory, and immune activity.

Medical uses with the strongest evidence

Treatment-resistant seizure disorders

One of the clearest medical applications involves purified CBD. The prescription drug Epidiolex is approved in the United States for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex. These are serious conditions that can be difficult to control with conventional antiseizure medicines.

This evidence applies to a standardized prescription product—not necessarily to CBD oils sold online or in retail stores, which may vary in purity and strength.

Chemotherapy-related nausea and vomiting

Cannabinoid medications can help control nausea and vomiting caused by chemotherapy, particularly when standard treatments are insufficient. The FDA has approved dronabinol, a laboratory-made form of THC, and nabilone, a synthetic cannabinoid, for this purpose.

Research suggests these medicines can be effective, although dizziness, sleepiness, and other side effects may limit their usefulness for some patients.

Appetite loss associated with HIV/AIDS

Dronabinol is also approved to treat appetite loss and weight loss in people living with HIV/AIDS. It may stimulate appetite, although the overall evidence for cannabis and cannabinoids in this area remains limited.

Chronic and neuropathic pain

Cannabis-based treatments may provide modest relief for certain types of chronic pain, particularly pain caused by nerve damage. However, the average benefit observed in clinical studies is generally small, and adverse effects occur more frequently than with placebo.

Cannabis should not automatically be viewed as a harmless replacement for opioids. Research has not established that adding cannabinoids consistently reduces opioid use, and treatment decisions should be made with a qualified healthcare professional.

Multiple sclerosis symptoms

Some cannabinoid preparations may modestly improve patient-reported muscle spasticity and pain associated with multiple sclerosis. Their effects are less convincing when spasticity is measured objectively, and benefits must be weighed against problems such as dizziness, fatigue, and impaired concentration.

Areas where the evidence remains uncertain

Cannabis is frequently promoted for anxiety, insomnia, post-traumatic stress disorder, inflammatory bowel disease, and many other conditions. Early studies occasionally suggest benefits, but the available evidence is often limited, inconsistent, or based on very small groups of patients.

Cannabis may help some people sleep because it reduces an underlying symptom such as pain. That is different from proving that it effectively treats insomnia itself. Likewise, CBD has shown preliminary potential for anxiety, but there is not yet enough strong evidence to treat ordinary retail CBD products as established anxiety medications.

Cannabis is also not considered an effective treatment for glaucoma. Although THC can temporarily lower pressure inside the eye, its effects do not last long enough to make it a practical substitute for conventional therapy.

Medical use is not risk-free

“Natural” does not mean harmless. THC can impair memory, coordination, judgment, and reaction time. Cannabis use is associated with an increased risk of traffic collisions, and people should never drive or operate machinery while impaired.

Other potential concerns include:

• Cannabis use disorder, dependence, and withdrawal
• Anxiety, paranoia, or psychotic symptoms, especially with high-THC products
• Dizziness and falls, particularly among older adults
• Recurrent severe vomiting in some long-term users
• Accidental poisoning of children from edible products
• Lung exposure and irritation when cannabis is smoked
• Medication interactions and possible liver injury associated with CBD
• Unreliable labeling or contamination in unregulated products

Cannabis use during pregnancy or breastfeeding is generally discouraged. Extra caution is also appropriate for adolescents, people with cardiovascular conditions, and anyone with a personal or family history of psychosis or substance-use disorders.

Cannabis is not the same as an approved medicine

The cannabis plant itself has not been approved by the FDA as a treatment for any disease. However, the agency has approved several standardized medicines containing purified or synthetic cannabinoids.

This distinction matters. Prescription products undergo testing for dosage, consistency, effectiveness, side effects, and drug interactions. Dispensary cannabis and over-the-counter CBD products can differ substantially in potency and may not contain exactly what their labels claim.

Laws governing medical cannabis also vary by location. Legal availability does not necessarily mean that every marketed use has been scientifically established.

The bottom line

Cannabis-derived medicines can offer meaningful benefits in specific circumstances—most notably certain severe seizure disorders, chemotherapy-related nausea and vomiting, and HIV/AIDS-related appetite loss. Some patients may also experience modest relief from chronic pain or multiple sclerosis symptoms.

At the same time, cannabis is not a cure-all. The benefits depend on the condition, product, dose, and individual patient, while the risks can be significant. Anyone considering medicinal cannabis should discuss it with a healthcare professional who understands their medical history and current medications.

The most useful question is not simply, “Does cannabis work?” It is: “Which cannabinoid product, for which condition, at what dose—and do the likely benefits outweigh the risks for this particular person?”

This article is for general educational purposes and is not a substitute for individualized medical advice.

Sources: National Center for Complementary and Integrative Health, U.S. Food and Drug Administration, and Centers for Disease Control and Prevention.